Invenomic Fund (BIVRX)
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio (greater than 80%), while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years ("unseasoned issuers") and in initial public offerings of securities ("IPO").
Fund Info
| ISIN | US66538F4708 |
|---|---|
| CUSIP | 66538F470 |
| Issuer | Invenomic |
| Inception Date | Jun 18, 2017 |
| Category | Long-Short |
| Min. Investment | $5,000 |
| Asset Class | Equity |
Asset Class Size | Mid-Cap |
Asset Class Style | Value |
Expense Ratio
The Invenomic Fund has a high expense ratio of 2.48%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BIVRX vs. QLEIX, BIVRX vs. BTC-USD, BIVRX vs. QQQ, BIVRX vs. SPY, BIVRX vs. FSCEX, BIVRX vs. PRWCX, BIVRX vs. UPRO, BIVRX vs. TMF, BIVRX vs. USNQX
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Invenomic Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Invenomic Fund had a return of -5.85% year-to-date (YTD) and -2.00% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -5.85% | 5.84% |
| 1 month | 2.13% | -2.98% |
| 6 months | -5.17% | 22.02% |
| 1 year | -2.00% | 24.47% |
| 5 years (annualized) | 25.03% | 11.44% |
| 10 years (annualized) | N/A | 10.46% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.69% | -7.39% | 3.79% | |||||||||
| 2023 | 1.70% | 1.10% | 0.17% | 0.98% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Invenomic Fund(BIVRX)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Invenomic Fund (BIVRX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Invenomic Fund granted a 21.51% dividend yield in the last twelve months. The annual payout for that period amounted to $3.91 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Dividend | $3.91 | $3.91 | $5.69 | $2.50 | $0.38 | $0.37 | $0.51 | $0.13 |
Dividend yield | 21.51% | 20.26% | 28.43% | 14.52% | 3.11% | 3.21% | 4.82% | 1.21% |
Monthly Dividends
The table displays the monthly dividend distributions for Invenomic Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | |||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.91 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.69 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.50 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.38 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.37 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.51 |
| 2017 | $0.13 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Invenomic Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Invenomic Fund was 25.39%, occurring on Mar 4, 2024. The portfolio has not yet recovered.
The current Invenomic Fund drawdown is 21.59%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -25.39% | Dec 12, 2023 | 56 | Mar 4, 2024 | — | — | — |
| -18.29% | Nov 6, 2019 | 91 | Mar 18, 2020 | 56 | Jun 8, 2020 | 147 |
| -16.57% | May 18, 2021 | 88 | Sep 21, 2021 | 61 | Dec 16, 2021 | 149 |
| -15.41% | Jun 9, 2020 | 22 | Jul 9, 2020 | 86 | Nov 9, 2020 | 108 |
| -14.33% | Jun 9, 2022 | 76 | Sep 27, 2022 | 66 | Dec 30, 2022 | 142 |
Volatility
Volatility Chart
The current Invenomic Fund volatility is 3.17%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.